Rani Therapeutics Holdings (RANI) Revenue (2020 - 2026)
Rani Therapeutics Holdings (RANI) posted quarterly Revenue of $1.7 million for Q1 2026, up 893.02% year-over-year from $172000.0 in Q1 2025, and up 16.91% quarter-over-quarter from $1.5 million in Q4 2025.
Rani Therapeutics Holdings (RANI) Revenue (2020 - 2026) Analysis & Trends
Rani Therapeutics Holdings' Revenue history runs 5 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Revenue rose 893.02% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $3.2 million (up 164.08% YoY), while the FY2025 annual figure was $1.6 million, up 58.85% from the prior year.
- Revenue for Q1 2026 stood at $1.7 million, up from $1.5 million in the prior quarter.
- The five-year high for Revenue was $1.7 million in Q1 2026, with the low at $172000.0 in Q1 2025.
- The 3-year median for Revenue is $1.2 million (2024), against an average of $1.1 million.
- The sharpest annual moves came in 2025 and 2026: Revenue soared 42.12% in 2025, then surged 893.02% in 2026.
- Rani Therapeutics Holdings' Revenue stood at $1.0 million in 2024, then jumped by 42.12% to $1.5 million in 2025, then increased by 16.91% to $1.7 million in 2026.
- Business Quant data shows RANI's Revenue at $1.7 million in Q1 2026, $1.5 million in Q4 2025, and $172000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 145.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.71 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.29 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 425.49 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 674.14 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 1.06 Bn |
| 10 | Rani Therapeutics Holdings | 160.33 Mn | 160.33 Mn | - | 1.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.71 Mn |
| Mar 31, 2026 | 1.71 Mn |
| Dec 31, 2025 | 1.46 Mn |
| Mar 31, 2025 | 172,000.00 |
| Dec 31, 2024 | 1.03 Mn |
| Jun 30, 2021 | 1.96 Mn |
| Mar 31, 2021 | 756,000.00 |
| Dec 31, 2020 | 210,000.00 |
| Sep 30, 2020 | 108,000.00 |
| Jun 30, 2020 | 60,000.00 |